Company Overview - BellRing Brands, Inc. is a consumer nutrition company that produces and sells ready-to-drink protein shakes, powders, bars, and other nutrition products under brands such as Premier Protein, Dymatize, and PowerBar [3]. Allegations of Wrongdoing - On May 6, 2025, BellRing disclosed during its quarterly earnings call that it anticipated a reduction in retailer inventory levels for the third quarter of 2025. The company projected "Q3 net sales growth of low-single-digits with Premier Protein the main driver and all others flat to down" [4]. - Following this announcement, BellRing's stock price experienced a significant decline, falling by $14.88 per share, or 18.97%, to close at $63.55 per share on the same day [4]. Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving BellRing, stemming from allegations of providing misleading business information to the investing public [1].

Company Overview - Lineage, Inc. is the largest temperature-controlled warehouse real estate investment trust (REIT) globally, operating over 450 cold-storage facilities across North America, Europe, and the Asia-Pacific [3]. Allegations and Financial Performance - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Lineage, stemming from allegations of providing misleading business information to investors [1]. - On July 24, 2024, Lineage completed its initial public offering of 56,882,051 shares at $78.00 per share [4]. - On April 30, 2025, Lineage reported a 2.7% decrease in total revenue, amounting to $1.29 billion for the quarter, attributing this decline to more normal seasonal trends after elevated inventory levels in previous years [4]. - Following the revenue report, Lineage's stock price fell by $8.26 per share, or 14.62%, closing at $48.23 per share on April 30, 2025 [4].

Company Overview - SelectQuote is a direct-to-consumer insurance platform that offers health, life, auto, and home insurance policies, as well as medication management services through its SelectRx pharmacy division [3] Allegations and Legal Issues - The Department of Justice filed a False Claims Act complaint against SelectQuote on May 1, 2025, alleging the company received millions of dollars in kickbacks from Humana in exchange for specific Medicare Advantage plan enrollments [4] - The complaint claims SelectQuote maintained a sales division that exclusively offered Humana policies and directed a significant portion of its business to Humana [4] Market Reaction - Following the filing of the complaint, SelectQuote's stock price fell by $0.61 per share, or 19.2%, closing at $2.56 per share on May 1, 2025 [5]

Company Overview - Semler Scientific, Inc. is a healthcare technology company focused on developing and marketing products for the early detection and management of chronic diseases, particularly through its flagship vascular testing device, QuantaFlo [3]. Allegations and Impact - On February 28, 2025, Semler filed its 2024 annual report with the SEC, revealing that the Department of Justice was considering a False Claims Act complaint regarding insurance reimbursement claims related to the QuantaFlo testing device [4]. - Following this disclosure, Semler's stock price dropped by $4.03 per share, representing a decline of 9.4%, closing at $38.89 per share on March 3, 2025 [4]. Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Semler, stemming from allegations of providing potentially misleading business information to investors [1].

Company Overview - Luminar Technologies is an automotive technology company focused on developing advanced sensors, software, and safety systems for autonomous vehicles [3] Allegations and Impact - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Luminar, stemming from allegations of providing misleading business information to investors [1] - On May 14, 2025, Luminar announced the resignation of its founder, President, and CEO Austin Russell, due to a business conduct and ethics inquiry by an internal audit committee [4] - Following the announcement of Russell's resignation, Luminar's stock price dropped by $0.80 per share, or 16.81%, closing at $3.96 per share on May 15, 2025 [4]

Company Overview - Fulgent Genetics, Inc. is a biotechnology company that specializes in diagnostic and genetic laboratory testing services and develops pharmaceutical treatments for various diseases and medical conditions [3] Allegations and Investigations - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Fulgent, stemming from allegations of providing potentially misleading business information to investors [1] - On February 28, 2025, Fulgent disclosed in its annual report that it received a civil investigative demand from the U.S. Department of Justice related to potential false claims submitted under the federal COVID-19 testing program for uninsured individuals [4] Market Reaction - Following the disclosure of the civil investigative demand, Fulgent's stock price declined by $0.41 per share, or approximately 2.61%, closing at $15.28 per share on March 3, 2025 [5]

Company Overview - New Fortress Energy, Inc. is an energy company that develops, finances, and operates liquefied natural gas (LNG) facilities and power plants globally [3] - The company operates through two segments: "Terminals and Infrastructure," focusing on LNG production and distribution, and "Ships," which provides LNG storage and transportation services [3] Allegations and Financial Performance - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving New Fortress due to allegations of providing misleading business information to investors [1] - On May 14, 2025, New Fortress announced its financial results for Q1 2025, reporting a total revenue decline of $219.8 million compared to Q1 2024, resulting in a net loss of $197.4 million, down from a net income of $56.7 million in the same quarter of the previous year [4] - Following the financial announcement, New Fortress' stock price fell by $4.27 per share, approximately 62.98%, closing at $4.27 on May 15, 2025 [5]